- PROFILE
- SERVICES
-
NAME PATIENT SUPPLYFDA Approved
-
Medical Oncology
- Bladder Cancer
-
Lung Cancer
- ALECENSA (Alectinib)
- ALIMTA (Pemetrexed)
- ALUNBRIG (Brigatinib)
- GILOTRIF (Afatinib)
- HYCAMTIN (Topotecan)
- IMFINZI (Durvalumab)
- MEKINIST (Trametinib)
- OFEV (Nintedanib)
- ORKAMBI (Lumacaftor/Ivacaftor)
- PORTRAZZA (Necitumumab)
- ROZLYTREk (Entrectinib)
- TABRECTA (Capmatinib)
- TRIKAFTA (elexacaftor/tezacaftor/ivacaftor)
- VARGATEF (Nintedanib)
- VIZIMPRO (Dacomitinib)
-
Prostate Cancer
- Apalutamide
- Abirapro (Abiraterone Acetate)
- Erleada (apalutamide)
- Jevtana (cabazitaxel)
- Kabanat (cabazitaxel)
- Lynparza (olaparib)
- Lupride (Leuprorelin)
- Nubeqa (darolutamide)
- Taxotere (docetaxel)
- Xtandi (Enzalutamide)
- Xbira (abiraterone acetate)
- Zoladex (goserelin acetate)
- Zytiga (Abiraterone acetate)
- Thyroid cancer
- Breast cancer
- Soft Tissue Sarcoma
- Colorectal Cancer
- Ovarian cancer
- Pancreatic cancer
- Liver Mediations
- Gastroenterology
- Adrenal cortical carcinoma
-
Hematology Medications
-
Leukemia Medications
- ATRIANCE (Nelarabine)
- BESPONSA (Inotuzumab ozogamicin)
- BLINCYTO (Blinatumomab)
- BOSULIF (Bosutinib)
- ERWINASE (Asparaginase)
- GLEEVEC (Imatinib)
- ICLUSIG (Ponatinib)
- MAB CAMPATH (Alemtuzumab)
- NEUPOGEN (Filgrastim)
- ONCASPAR (Pegaspargase)
- ONUREG (azacitidine)
- RYDAPT (Midostaurin)
- SYNRIBO (Omacetaxine mepesuccinate)
- TARCEVA (Erlotinib)
- TASIGNA (Nilotinib)
- VENCLEXTA (Venetoclax)
- VYXEOS (Daunorubicin and Cytarabine)
- XOSPATA (Gilteritinib)
- ZYDELIG (Idelalisib)
- Lymphoma Medications
- Melanoma Medications
- Multiple Myeloma Medications
-
Leukemia Medications
- Asthama
- Bone Marrow
- Brain Tumor
- Cardiology
- Crohn's disease
- Gastroenterology
- Heart Disease
- Dermatology
- Multiple Sclerosis
- Kidney
- PARSABIV (etelcalcetide)
- PROCYSBI (cysteamine bitartrate)
-
Medical Oncology
- Rheumatoid Arthritis
- Weight Management
-
Others
- Aducanumab
- Amisulpride
- eptinezumab-jjmr
- Cabotegravir/rilpivirine
- Cymevene (Ganciclovir)
- Eptinezumab-JJMR
- EMGALITY (Galcanezumab-gnlm)
- Gutron (midodrine)
- Dextromethorphan / Bupropion
- Ilaris (canakinumab)
- Kanuma (sebelipase-alfa)
- Lactitol
- Osilodrostat
- Rimegepant
- Reblozyl (luspatercept-aamt)
- Soliris eculizumabeculizumab)
- Somavert (pegvisomant)
- Tazemetostat
- Teprotumumab
- Ubrogepant
- Unituxin (dinutuximab)
- Vistide (Cidofovir)
- Vitrakvi (larotrectinib)
- Xadago (safinamide)
- Xermelo (telotristat ethyl)
- Zostavax (zoster vaccine live)
- ZOLGENSMA (Onasemnogene abeparvovec-xioi)
-
Medical Oncology
- Brain Cancer
- Breast Cancer
- Colorectal Cancer
- Gastric Cancer
- Liver Cancer
-
Lung Cancer
- Afatinib
- Alectinib
- Avastin (bevacizumab)
- Crizalk (Crizotinib)
- Cyendiv (nintedanib)
- Erlonat (Erlotinib)
- Geftinat (Gefitinib)
- Crizotinib
- Erlotinib
- Gefitinib
- Gemcitabine
- Nintena (Nintedanib)
- Nintedanib
- Nivolumab
- Paclitaxel Injection
- Pemnat (Pemetrexed)
- Pembrolizumab
- Tagrisso (Osimertinib)
- Tecentriq
- Xalkori (crizotinib)
- Prostate Cancer
- Stomach Cancer
- Haemto Oncology
- PPE Kits
- Body Infrared Thermometer
- Auto Sanitization Tunnel Gate
- Sanitizer Tunnel / Walkaway
- Mask Disinfection Machine
- Patient monitoring & IT products
- Anaesthesia machines
- Thermoregulation
- Ventilation & respiratory monitoring
- Alaris™ GP Plus Volumetric Pump
- Alaris™ Pump infusion sets
- HemoCue Point-of-Care